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Background: Oral health is an important part of general physical health and is essential for self-esteem, self-confidence
and overall quality of life. There is a well-established link between mental illness and poor oral health. Oral health
problems are not generally well recognized by mental health professionals and many patients experience barriers
to treatment.
Methods/Design: This is the protocol for a pragmatic cluster randomised trial that has been designed to fit within
standard care. Dental awareness training for care co-ordinators plus a dental checklist for service users in addition
to standard care will be compared with standard care alone for people with mental illness. The checklist consists
of questions about service users’ current oral health routine and condition. Ten Early Intervention in Psychosis (EIP)
teams in Nottinghamshire, Derbyshire and Lincolnshire will be cluster randomised (five to intervention and five to
standard care) in blocks accounting for location and size of caseload. The oral health of the service users will be
monitored for one year after randomisation.
Trial registration: Current Controlled Trials ISRCTN63382258.Background
Oral health is an important part of physical health and
is essential for self-esteem, self-confidence and overall
quality of life [1,2]. Oral diseases are the most common
chronic disease and have a great impact on individuals
[3]. Oral health is not just about having healthy teeth it
is a ‘standard of health of the oral and related tissues
which enables an individual to eat, speak and socialise
without active disease, discomfort or embarrassment
and which contributes to general well-being’ [1]. It has
often been the case that when a person has a serious
mental illness and are unwell, their oral health may not
be seen as a priority, so it is neglected and deteriorates
[2]. Oral health problems are often not detected by* Correspondence: Hannah.Jones@nottingham.ac.uk
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reproduction in any medium, provided the ormental health professionals [4] and, to compound the
matter, many dentists shy away from treating people
with psychosis [5,6].
Research conducted in the last decade that has ex-
amined the oral health of people with serious mental
illness has generally concluded that oral health for
people with serious mental illness is poor compared
with the general population [7-11]. People with serious
mental illness are likely to experience more oral health
problems and require more dental treatment than
people from the general population [2]. Side effects of
medication prescribed to people with serious mental
illness can cause a lack of saliva, which in itself can
lead to caries [12-15].
Guidelines
The British Society for Disability and Oral Health guide-
lines published in 2000 made a number of recommenda-
tions for oral health care for people with mental healthtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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port, promotion and education addressing the oral
health needs of clients [2]. We are not aware of other
guidelines regarding dental care for people who have
been diagnosed with serious mental illness, practical
advice is missing.
Surveys
Recent surveys that have described the current oral
health of people with serious mental illness in vari-
ous settings, have concluded that the oral health of
people with serious mental illness is poor, and many
have indicated that it is significantly worse than the
general population [16].
Systematic reviews
A recent systematic review and meta-analysis of ad-
vanced dental disease in people with severe mental ill-
ness found that people with mental illness were 3.4
times more likely to have lost teeth than the general
population and had higher rates of decayed, missing or
filled teeth [17]. A meta-analysis of 57 studies looking
at the prevalence of suboptimal oral health of people
with mental illness and describing approaches to pro-
mote oral health [18], found a suboptimal oral health
prevalence of 61% as well as highlighting the need for
oral health training for mental health professionals. A
recent Cochrane review [19] found no relevant randomised
trials comparing an oral health advice intervention
with standard care for people with serious mental ill-
ness that met the inclusion criteria. Another Cochrane
review assessed the effectiveness of physical health moni-
toring as a means of reducing morbidity, mortality and
improving quality of life in people with serious mental
illness but also found no trials meeting the inclusion
criteria [20].
Trials
There are very few randomised controlled trials of moni-
toring or advice regarding physical health care for people
with serious mental illness. One small trial randomised
sixty people to interventions of motivational interviewing
plus oral health education or oral health education alone
and found that the oral health of individuals who re-
ceived the motivational interviewing improved signifi-
cantly more compared to oral health education alone
[14]. Another trial randomly assigned 100 participants to
receive professional hygienic training or to a no treat-
ment control group and also compared the effectiveness
of the intervention for those treated with classical neuro-
leptics and atypical neuroleptics [21]. Results showed
that the effectiveness of oral hygiene training for people
receiving classical neuroleptics was lower than for those
receiving atypical neuroleptics.Objectives
To examine whether dental awareness training plus a
dental checklist leads to a clinically significant difference
in oral health behaviour of people with serious mental
illness.
Design
Setting
The trial will be conducted as part of standard care pro-
vided by the Early Intervention in Psychosis (EIP) teams
in Nottinghamshire, Derbyshire and Lincolnshire (UK).
These three shires are located in the East Midlands of
England and each have a mixture of urban and rural
areas with a diverse population. The EIP teams provide
intensive treatment and support to people with a first
experience of symptoms such as hearing voices or those
who develop unusual beliefs which may indicate the on-
set of psychosis. Care co-ordinators are the main contact
person for service users throughout their involvement
with the service; it is the care co-ordinators who will be
delivering the intervention in this trial to their service
users.
The three shires dental trial was designed with consid-
erable collaboration with EIP clinicians and service users
to make it acceptable to be delivered with minimal dis-
ruption alongside standard care. The dental checklist
(see Additional file 1) was adapted from the British Society
for Disability and Oral Health (BSDH) guidelines [2] in de-
sign workshops with researchers, clinicians, service users
and carers.
Sample size
No previous trials exist [19]. It is, therefore, difficult
to determine the number of people that need to be
recruited to generate clinically significant data regard-
ing the effect of an oral health advice intervention on
the oral health of people with a serious mental illness.
As we designed the study in consultation with clini-
cians and service users, we tried to gain an impression
of the size of difference that would cause a change in
practice. We did not formally record these estimates,
but consensus suggested a range of between 10% to
20%. We estimate the sample size for the mid-way point
(Table 1).
Complicating this further is that this is a cluster trial
so the EIP teams will be randomised as a whole team ra-
ther than at the individual patient level. Intraclass correl-
ation coefficient (ICC) in cluster trials are difficult to
estimate if no previous studies exist and to not take clus-
tering into account would lead to ignoring the potential
for a unit-of-analysis error [22-24]. Simply estimating
that we will be able to randomise the people for whom
the 10 teams provide care into two groups is not an ac-
curate reflection of the power of the study. This has to
Table 1 Sample size needed to detect an absolute difference of 15% in the proportion of visits to a dentist (α = 5%,
power = 80%)
Standard care, % Dental intervention, % Non-cluster N (total) Multiplied by design effect Adjusted for 20% dropout
5 20 176 334 418
10 25 226 430 538
15 30 268 510 638
20 35 302 574 718
25 40 330 628 785
30 45 352 670 837
35 50 366 696 870
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ing. There are two levels of clustering within this trial,
the EIP teams are the clusters that will be randomly
allocated to receive the interventions but there are
also clusters within the teams; the individual care co-
ordinators. Non-cluster N was calculated using the
Stata version 11 software (StataCorp, College Station,
TX, USA) with alpha = 0.05, power = 0.80. The de-
sign effect (DE) was calculated considering patients
clustered within each staff/team and each staff sees 10
patients (DE = 1+ (10–1)*0.1 = 1.9), with an intracluster
coefficient of 0.1 as a best guess.
Assuming that 5% of the service users who receive
standard care visit a dentist, to then detect a 15% in-
crease in the proportion of those who visit a dentist in
the dental intervention arm with 80% power at 0.05 sig-
nificance level, we need 176 service users for a single-
centre trial, after adjusting for the cluster effect by
multiplying this by the design effect, we need to recruit
334 service users. After further adjusting for 20% of ser-
vice users lost to follow up, the final number of service
users we need to recruit is 418. Other situations with
various proportions of visits to a dentist in standard care
are also presented in Table 1.
All these assumptions we have made in this power cal-
culation may be correct or all may be incorrect. It is, at
this point, quite impossible to say. As can be seen from
the background, no studies have been undertaken in this
area. There is no data to even guess what any effect may
or may not be. This is a pioneering trial that will set a
standard and will allow researchers in the future to have
some benchmark off which to work.
Ethical considerations
EIP team managers will be asked to consent to the trial
being conducted within their teams. Informed consent
will be sought from care co-ordinators in accordance
with Research Ethics Committee (REC) and Good Clin-
ical Practice (GCP) guidance. Service users will be asked
by the care co-ordinator if they agree to the care co-
ordinator completing the dental checklist at the time oftheir regular appointment. Service users will not give
formal consent for this trial, agreeing to answer the
questions on the dental checklists is their consent. This
is standard for routine care and public health measures.
This is due to the intervention being aimed at the care
co-ordinators who receive the dental awareness training,
and it is the effect of this training and the checklist that
is being measured and not the responses of each service
user. The effect of this combined intervention will influ-
ence the service users’ dental awareness, even if they do
not complete the checklist. It will be made clear to the
service users that they do not have to answer the ques-
tions if they wish and this will have no detrimental effect
on their standard care. If the need arises, relevant infor-
mation only will be disclosed to the care co-ordinator or
another relevant individual in authority.
The trial has received a favourable opinion from the
East Midlands Nottingham Research Ethics Committee
(REC reference 11/EM/0205) and from the Nottingham-
shire, Derbyshire and Lincolnshire National Health Service
(NHS) Research and Development (R&D) departments.
The trial team have research passports, GCP training,
Criminal Records Bureau checks and letters of access for
each NHS Trust.
All data will be made anonymous and stored securely.
Changes to the protocol will not be implemented until
the amendments or revised documents have received
favourable opinion from the REC and R&D departments.
A protocol amendment intended to eliminate an apparent
immediate hazard to participants may be implemented im-
mediately and the REC will be notified as soon as possible
to request approval. Minor protocol amendments for logis-
tical or administrative reasons may be implemented imme-
diately and the REC will be informed.
Methods
Randomisation
This is a pragmatic, open, cluster randomised controlled
trial. We are limited by the number and size of the teams
as well as by the compliance of the care co-ordinators.
The Nottingham Clinical Trials Unit (CTU) will create a
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searcher to randomise the EIP teams. The researcher will
list the teams in such a way as to anonymise them, we
will then block randomise; the block being the number of
teams within each county. This will ensure that each
county gets some degree of exposure to the intervention.
EIP teams will be grouped into pairs according to loca-
tion and size of team, which will then be randomised
with one team being allocated the active intervention
and the other the control. Randomisation will be strati-
fied to ensure that both of the interventions are roughly
equal in terms of team location, number of care co-
ordinators within the team and size of caseloads. The
CTU will keep full records of the procedure, but there
will be no requirement for having procedures for break-
ing code.
Participants
Care co-ordinators will be recruited by the EIP team
managers and the trial team, and service users will be
recruited by the care co-ordinators. Care co-ordinators
will be informed of all aspects concerning participation
in the trial.
Inclusion criteria
Any EIP team in Nottinghamshire, Derbyshire and
Lincolnshire and any service users under the care of a
care-coordinator in one of these teams, who is aged 18
years or above will be included. Any concomitant treat-
ments are allowed.
Exclusion criteria
Any EIP team that does not wish to take part and any
individual care co-ordinator who feels that they do not
wish to take part will be excluded. The data from service
users under the age of 18 at randomisation will not be
collected. People who are unable to provide informed
consent will be excluded.
Removal of participants from therapy or assessments
Teams or care co-ordinators within each team can with-
draw at any time. They will have given consent but could
decide to withdraw that consent. All data up to the point
of withdrawal will be used. Withdrawal from the study
would result in resumption of standard care. Service
users will be withdrawn if a team or care co-ordinator
removes their consent.
Participants may be withdrawn from the trial either at
their own request or at the discretion of the Investigator.
Service users will be made aware that this will not affect
their future care. All participants will be made aware
(via the information sheet and consent forms) that
should they withdraw the data collected to date cannot
be erased and may still be used in the final analysis.Procedure
Before teams are randomised, all managers will be given
information sheets and asked to sign a consent form
providing permission for their team to be involved in
the trial. We will collect demographic information about
the EIP teams to create a list of eligible service users and
a cross-coding sheet by which each service user can be
allocated an anonymous trial ID. Demographic information
will include team location, number of care co-ordinators
within the team, size of caseloads and distance to dental
services from the team base. The trial team will not have
access to identifiable NHS data.
Dental intervention
After randomisation, EIP teams allocated to receive the
dental intervention will be approached by the trial team
to arrange a convenient time to conduct the one-off
dental awareness training at the start of the 12-month
intervention period. Information sheets will be given out
to care co-ordinators and consent forms will be signed.
This will fit within the usual multidisciplinary team
meetings, but is likely to take around 30 minutes, includ-
ing time for questions and shared experiences. There will
be a manual in order to keep it consistent for all teams
(see Additional file 2). The training will briefly cover the
aims and background of the trial, how to complete the
checklist, service user ID number allocation, how to re-
turn the completed checklists to the trial team and dis-
cussion about what to do in certain situations regarding
adverse events. The care co-ordinators will be encour-
aged to use the checklist for all their service users at
their earliest convenience. The checklist is printed on
carbonless copy paper, one copy of the dental checklist
will be kept in the service users’ notes and one will be
returned in pre-paid envelopes to the trial team. Care
co-ordinators will also be encouraged to offer their ser-
vice users an oral hygiene information sheet which con-
tains oral hygiene tips and information on how to find
an NHS dentist (see Additional file 3).
Control group
EIP teams allocated to the control group will continue
to deliver standard care for 12 months. They will receive
the dental awareness training and will be asked to use
the dental checklist one year after the intervention
group, following the same procedure as the intervention
group. Care co-ordinators in control teams will be given
information sheets and asked to sign consent forms.
Follow-up
The trial team will prompt the intervention group care
co-ordinators for the 12-month follow-up where dental
checklists will be completed again for all service users. A
total of 100 service users will be randomly selected from
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to ask them if contact from the trial team is acceptable re-
garding the Oral Impacts on Daily Performance (OIDP)
measure as well as for collecting detailed data from their
dentists (if they have visited a dentist within the previous
12 months). If it is not - no contact will be made. For this
person, the trial is then over. The OIDP is a scale which as-
sesses the impacts to which dental problems affect an indi-
vidual’s life on a daily basis (see Additional file 4).
All service users who have indicated that contact from
the trial team is acceptable will be contacted by an inde-
pendent researcher and consent gained for conduct. For
the OIDP information sheets will be given out and con-
sent forms will be signed. The OIDP will then be admin-
istered as a short 20-minute interview by the researcher.
For the detailed dental data, information sheets will be
given out and consent forms will be signed. Dentists will
then be contacted and information about recent dental
treatment and current state will be requested Figure 1.Figure 1 CONSORT flow diagram of participants through the trial.Serious unexpected events
Adverse events due to participating in this trial are not
expected. Service users’ mental health will be closely
monitored by their EIP teams, care co-ordinators will be
asked to inform the trial team of any adverse event that
either the care co-ordinator or service user feels was due
to the checklist. The trial team will determine the ser-
iousness and causality in conjunction with any treating
medical practitioners. Serious adverse events are divided
into two categories, those that seem likely to be independ-
ent of an oral checklist and those connected to oral
healthcare. All adverse events will be recorded and closely
monitored until resolution, stabilisation, or until it has
been shown that involvement in the trial is not the cause
by the data monitoring committee. All treatment-related
serious adverse events will be recorded and reported to the
REC as part of the annual reports. Unexpected serious ad-
verse events will be reported to the REC by the chief inves-
tigator who will take appropriate medical action, which
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of such action. If the event is determined to be due to
involvement in the trial the REC will be informed using
the reporting form found on the NRES web page within
seven days of knowledge of the event. Within a further
eight days, the trial team will send any follow-up infor-
mation and reports to the REC. Any necessary amend-
ments to the protocol will be made and the REC will be
informed as required. Any participant who experiences
an adverse event may be withdrawn from the study at
the discretion of the investigator.
Outcomes
Primary outcomes
Number of service users who have visited a dentist within
12 months of exposure to the checklist as reported on the
checklist.
Secondary outcomes
Registered with a dentist, routine check-up within the last
12 months, owning a toothbrush, cleaning teeth twice a
day, non-routine visit to a dentist in the last year, replacing
existing toothbrush within the last six months, problems
with mouth and teeth, OIDP. A cost analysis will also be
carried out and other outcomes will include whether any
service users have left the EIP service for any reason,
including whether they refused to give consent, were
discharged to another service, or whether they passed away.
Data
Data analysis
This is a cluster randomised controlled trial with a small
number of clusters but many participants within the
clusters. We anticipate 600 to 800 dental checklists to be
completed during the trial. The analysis will focus on
whether the intervention has made a clinically significant
difference to the data collected from the intervention
teams (Additional file 5). The expected analysis will
be a multilevel modelling or random effects methods.
We will not analyse any difference between the care
co-ordinators. . Data will be entered into a password-
protected database with an audit trail.
Health economic analysis
This trial has been designed to be inexpensive to run
but there will be some cost associated with training ses-
sions and some staff time associated with completing
the checklists, as well as addressing the dental needs of
the service users. It is anticipated that more dental ap-
pointments will be made in the intervention teams, and
the cost of these to the service user, EIP team and NHS
dentist should be calculated.
There are two arms to this trial; the dental interven-
tion delivered alongside standard care or standard carealone. The dental intervention includes a one-off session
of dental awareness training provided to care co-
ordinators within individual EIP teams, a dental infor-
mation sheet provided to service users and a checklist
that will be completed with each service user. This
would thus lead to resource use including but not limited
to planning, formulation, training and implementation of
the dental awareness training as well as staff contact time
for completion of checklists. Increase in level of staff input
(contact time) as well as additional dental visits will need
to be recorded. The cost-effectiveness analysis will be from
the perspective of the National Health Service (NHS) in
England, as we will plan on looking at the incremental
cost-effectiveness ratio.
As this is the first pragmatic trial of oral health advice
for people with serious mental illness, there is an uncer-
tainty as to the magnitude of difference in effectiveness
in the two arms of the trial. Should there be a statistically
significant difference between the two groups, we would
proceed with a full economic evaluation including cost-
effectiveness analysis and cost-utility analysis (possible
as the OIDP will be administered to a sample of 100
patients). However, should there be no difference, we
would conduct a partial economic evaluation in the
form of a cost analysis. The primary outcome measure
for this trial is number of visits to the dentist within 12
months of exposure to the checklist.
Data regarding dental visits from a subsample of 100
service users will be obtained at the end of the study
period and the difference in dental visits between the
two groups can be used in calculation of the incremental
cost-effectiveness ratio. The effectiveness data could also
be calculated as a potential savings to the NHS for
varied dental treatment due to early detection of den-
tal pathology.
The estimated unit cost of the intervention and stand-
ard care will be based on 2012 to 2013 reimbursement
rates for the NHS. The costs will be determined by
multiplying the resources used and their volumes by the
estimated cost per unit. A cost-effectiveness analysis is a
form of economic evaluation that compares the relative
costs and effects of two alternative options. In this trial
the incremental cost-effectiveness ratio will be the ratio
wherein the denominator would be patients keeping
their dental appointments during the year (or Decayed,
Missing and Filled Teeth (DMFT) rates if available) and
the numerator would be the cost associated with the
health gain. Based on data obtained, a detailed probabil-
istic sensitivity analysis will be carried out in order to
get a range of incremental cost-effectiveness ratios.
Procedures for missing data
Some service users may leave the study early, but we
plan to follow up as many as possible. We plan to carry
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whether data missing is at random and whether the leav-
ing early has an effect on treatment effects. To see if the
data is missing at random, we will analyse whether it
correlates to or is associated with the rest of the data.
For data missing at random, a multiple imputation
method will be used to fill missing values. If data miss-
ing is not at random or it may bias treatment effects, we
shall run a selection-bias correction model (mixture
model) to adjust for such bias.
Data monitoring
Monitoring of trial data includes confirmation of in-
formed consent, source data verification, data storage
and data transfer procedures, local quality control checks
and procedures, back-up and disaster recovery of any
local databases and validation of data manipulation. En-
tries on Case Report Forms (CRFs) will be verified by in-
spection against the source data. A sample of CRFs (10%
or as per the study risk assessment) will be checked on a
regular basis for verification of all entries made. In
addition, the subsequent capture of the data on the trial
database will be checked. Where corrections are required,
these will carry a full audit trail and justification as to
why amendments were made.
Trial data and evidence of monitoring and systems au-
dits will be made available for inspection by the REC as
required. In keeping with the GCP guidelines and in ac-
cordance with the University of Nottingham’s Research
Code of Conduct, the chief investigator will maintain all
records and documents regarding the conduct of the
study, which will be kept for at least seven years or for
longer if required. If the responsible investigator is no
longer able to maintain the study records, a second per-
son will be nominated to take over this responsibility.
The trial master file and trial documents held by the
chief investigator on behalf of the sponsor shall be finally
archived at secure archive facilities at the University of
Nottingham. This archive shall include all trial databases
and associated meta-data encryption codes.
Governance
The Advisory Group is a multidisciplinary group to give
advice and direction to the overall project and will meet
every six weeks to begin with but will also provide con-
tinuing support and meet every few months for the
duration of the trial. The Steering Group will meet
twice a year to monitor the overall progress of the trial,
adherence to the protocol and patient safety. The Data
Monitoring Group will meet once a year to assess the
progress and safety of the trial while providing the
sponsor with recommendations regarding trial modifi-
cation, continuation or termination. The Management
Group consists of the trial team and will meet everyweek regarding the day-to-day running of the trial and
data collection. This group will also communicate any
unexpected events to both the Steering Group and the
Advisory Group.
Trial status
Recruitment started in February 2012. As of August 2012,
10 EIP teams caring for a total of 1,074 service users
have been randomised. Recruitment for new trial sites
is underway.
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